Epidemiology, co-morbidities, and medication use of patients with alzheimer's disease or vascular dementia in the UK

Journal of Alzheimer's Disease

Volumn 35, Issue 3, 2013, Pages 565-573

  Imfeld, Patrick ^a   Brauchli Pernus, Yolanda B ^a   Jick, Susan S ^b   Meier, Christoph R ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; comorbidity; dementia; epidemiology; vascular

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; ENTERITIS; EPILEPSY; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; ORTHOSTATIC HYPOTENSION; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THYROID DISEASE; UNITED KINGDOM;

EID: 84880226575     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121819     Document Type: Article

References (37)

1. World Health Organisation (WHO), The global burden of disease: 2004 update, http: //www.who.int/healthinfo/global burden disease/2004 report update/en/index.html, Accessed August 12, 2012.
2. Alzheimer's Society, Dementia UK, http: //www.alzheimers. org.uk/site/scripts/download info.php?fileID=2&categoryID =200120, Accessed August 12, 2012.
3. Health Economics Research Centre, University of Oxford, Dementia 2010, http: //www.dementia2010.org/, Accessed August 12, 2012.
4. Matthews F, Brayne C (2005) The incidence of dementia in England and Wales: Findings from the five identical sites of the MRC CFA Study. PLoS Med 2, e193.
5. Copeland JR, McCracken CF, Dewey ME,Wilson KC, Doran M, Gilmore C, Scott A, Larkin BA (1999) Undifferentiated dementia, Alzheimer's disease and vascular dementia: Age- and gender-related incidence in Liverpool. The MRCALPHA Study. Br J Psychiatry 175, 433-438.
6. Paykel ES, Brayne C, Huppert FA, Gill C, Barkley C, Gehlhaar E, Beardsall L, Girling DM, Pollitt P, O'Connor D (1994) Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 51, 325-332.
7. Holstein J, Chatellier G, Piette F, MouliasR(1994) Prevalence of associated diseases in different types of dementia among elderly institutionalized patients: Analysis of 3447 records. J Am Geriatr Soc 42, 972-977.
8. Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK (2002) Co-morbidity associated with dementia. Am J Alzheimers Dis Other Demen 17, 73-78.
9. Eaker ED, Mickel SF,Chyou P-H, Mueller-Rizner NJ, Slusser JP (2002) Alzheimer's disease or other dementia and medical care utilization. Ann Epidemiol 12, 39-45.
10. HillJW, Futterman R, Duttagupta S, MasteyV, Lloyd JR, Fillit H (2002) Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology 58, 62-70.
11. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J (2001) The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 49, 277-283.
12. Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350, 1097-1099.
13. Jick H (1997) A database worth saving. Lancet 350, 1045-1046.
14. Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodriguez LA, Ruigomez A, Meier CR, Schlienger RG, Black C, Jick H (2003) Validity of the general practice research database. Pharmacotherapy 23, 686-689.
15. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302, 766-768.
16. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition(DSMIV), American Psychiatric Association, Washington, D.C.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
18. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
19. National Institute for Health and Clinical Excellence (NICE) (2006) Dementia - Supporting people with dementia and their carers in health and social care, London.
20. Scottish Intercollegiate Guidelines Network (SIGN) (2006) Management of patients with dementia, Edinburgh.
21. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Gender differences in the incidence ofADand vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53, 1992-1997.
22. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D (2002) Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 50, 41-48.
23. L'opez-Pousa S, Vilalta-Franch J, Lliǹas-Regla J, Garre-Olmo J, Roman GC (2004) Incidence of dementia in a rural community in Spain: The Girona cohort study. Neuroepidemiology 23, 170-177.
24. Bermejo-Pareja F, Benito-Le'on J, Vega S, Medrano MJ, Roman GC (2008) Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 264, 63-72.
25. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E (2002) Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 59, 1589-1593.
26. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB (2002) Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol 59, 1737-1746.
27. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA (2001) Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 153, 132-136.
28. Fratiglioni L, Launer LJ, Andersen K, BretelerMM,Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15.
29. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM (2001) Incidence of dementia: Does gender make a difference? Neurobiol Aging 22, 575-580.
30. Alzheimer's Society, Alzheimer's Scotland, and Tesco, Mapping the Dementia Gap, http: //alzheimers.org.uk/site/scripts/download info.php?downloadID=554, Accessed August 12, 2012.
31. National Institute for Health and Clinical Excellence (NICE) (2006) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (amended), London.
32. Launer LJ, RossGW, Petrovitch H, Masaki K, FoleyD,White LR, Havlik RJ (2000) Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 21, 49-55.
33. Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009) Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 28, 75-80.
34. Irie F, Fitzpatrick AL, Lopez OL,Kuller LH, Peila R, Newman AB, Launer LJ (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: The Cardiovascular Health Study Cognition Study. Arch Neurol 65, 89-93.
35. Löppönen MK, Isoaho RE, Räihä IJ, Vahlberg TJ, Loikas SM, Takala TI, Puolijoki H, Irjala KM, Kivela SL (2004) Undiagnosed diseases in patients with dementia-a potential target group for intervention. Dement Geriatr Cogn Disord 18, 321-329.
36. Li N-C, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis. BMJ 340, b5465.
37. Hajjar I, Brown L, Mack WJ, Chui H (2012) Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol 69, 1632-1638.